Grifols ADRs Tumble After Brookfield Reportedly Backs Away from Takeover Bid
Grifols' American depositary receipts slumped following a report that Brookfield Asset Management plans to abandon its acquisition of the Spanish pharmaceuticals company. The stock was down 18% at $7.14 in premarket trading. Shares had already fallen nearly 25% year-to-date when the market closed Tuesday.